drugset / Trial / NCT07433426

The Impact of Shigellosis and Recommended Treatment in Children

NCT07433426

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate whether antibiotic treatment of non-dysentery Shigella associated watery diarrhea (NDSD) cases improves clinical outcomes and growth in children. Children with NDSD seeking care for diarrhea at the study hospitals in Bangladesh and Zambia will be enrolled and randomized to receive Azithromycin or placebo (a look-alike substance that contains no drug). Enrolled children will be followed for three months with household visits. The investigators will determine whether antibiotic treatment of NDSD reduces the duration of diarrhea and time to microbiological cure (shedding of Shigella in stool), and whether it improves growth in children compared with the placebo group.

Timeline

Start
2026-03-18
Primary completion
2029-08
Completion
2030-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 10 mg/kg

Indications